CPA4 levels were elevated in 32.1% of the breast tissue samples (45/140), and positive staining for CPA4 was statistically significantly associated with lymph node metastasis and stage. This evidence concerns the gene CPA4 and metastatic malignant neoplasm in the lymph nodes.